The effect of nursing intervention combined with PD-1 inhibitor on platelets, white blood cells, tumor markers and quality of life in patients with lung cancer

References

• Abdin, A. A., Soliman, N. A., & Saied, E. M. (2014). Effect of propranolol on IL-10, visfatin, Hsp70, iNOS, TLR2, and survivin in amelioration of tumor progression and survival in Solid Ehrlich Carcinoma-bearing mice. Pharmacological Reports, 66(6), 1114–1121. https://doi.org/10.1016/j.pharep.2014.07.010
   PubMedGoogle Scholar
• Chang, L., Chang, M., Chang, H. M., & Chang, F. (2018). Microsatellite instability: A predictive biomarker for cancer immunotherapy. Applied Immunohistochemistry & Molecular Morphology, 26(2), e15–21. https://doi.org/10.1097/PAI.0000000000000575
   Web of Science ®Google Scholar
• Chan, T. A., Yarchoan, M., Jaffee, E., Swanton, C., Quezada, S. A., Stenzinger, A., & Peters, S. (2019). Development of tumor mutation burden as an immunotherapy biomarker: Utility for the oncology clinic. Annals of Oncology, 30(1), 44–56. https://doi.org/10.1093/annonc/mdy495
   PubMed Web of Science ®Google Scholar
• Coyne, B. (2016). Mouth cancer for clinicians part 7 (Dent update 2016; 50-65). Dental Update, 43(2), 193. https://doi.org/10.12968/denu.2016.43.2.193b
   PubMedGoogle Scholar
• Dmitrieva-Posocco, O., Dzutsev, A., Posocco, D. F., Hou, V., Yuan, W., Thovarai, V., Mufazalov, I. A., Gunzer, M., Shilovskiy, I. P., & Khaitov, M. R. (2019). Cell-type-specific responses to interleukin-1 control microbial invasion and tumor-elicited inflammation in colorectal cancer. Immunity, 50(1), 166–180. e167. https://doi.org/10.1016/j.immuni.2018.11.015
   PubMed Web of Science ®Google Scholar
• Ghorbani, M., Mohammadi, E., Aghabozorgi, R., & Ramezani, M. (2021). The effect of applying spiritual care model on well-being and quality of care in cancer patients. Supportive Care in Cancer, 29(5), 2749–2760. https://doi.org/10.1007/s00520-020-05781-7
   PubMedGoogle Scholar
• Haley, W. E., Levine, E. G., Brown, S. L., & Bartolucci, A. A. (1987). Stress, appraisal, coping, and social support as predictors of adaptational outcome among dementia caregivers. Psychology and Aging, 2(4), 323. https://doi.org/10.1037/0882-7974.2.4.323
   PubMed Web of Science ®Google Scholar
• Imai, H., Minemura, H., Sugiyama, T., Yamada, Y., Kaira, K., Kanazawa, K., Kasai, T., Kaburagi, T., Minato, K., & Group, G. -I. -F. -T. (2018). Efficacy and safety of cytotoxic drug chemotherapy after first-line EGFR–TKI treatment in elderly patients with non-small-cell lung cancer harboring sensitive EGFR mutations. Cancer Chemotherapy and Pharmacology, 82(1), 119–127. https://doi.org/10.1007/s00280-018-3596-6
   PubMedGoogle Scholar
• Kashiwabara, K., Semba, H., Fujii, S., & Tsumura, S. (2018). Toxicity and efficacy of sequential chemotherapy in patients with p-stage I non-small cell lung cancer that recurring during postoperative tegafur-uracil adjuvant chemotherapy. Cancer Investigation, 36(8), 424–430. https://doi.org/10.1080/07357907.2018.1515954
   PubMed Web of Science ®Google Scholar
• Kawa, M., Kayama, M., Maeyama, E., Iba, N., Murata, H., Imamura, Y., Koyama, T., & Mizuno, M. (2003). Distress of inpatients with terminal cancer in Japanese palliative care units: From the viewpoint of spirituality. Supportive Care in Cancer, 11(7), 481–490. https://doi.org/10.1007/s00520-003-0460-x
   PubMedGoogle Scholar
• Khunger, M., Jain, P., Rakshit, S., Pasupuleti, V., Hernandez, A. V., Stevenson, J., Pennell, N. A., & Velcheti, V. (2018). Safety and efficacy of PD-1/PD-L1 inhibitors in treatment-naive and chemotherapy-refractory patients with non–small-cell lung cancer: A systematic review and meta-analysis. Clinical Lung Cancer, 19(3), e335–348. https://doi.org/10.1016/j.cllc.2018.01.002
   PubMed Web of Science ®Google Scholar
• Kral, J. B., Schrottmaier, W. C., Salzmann, M., & Assinger, A. (2016). Platelet interaction with innate immune cells. Transfusion Medicine and Hemotherapy, 43(2), 78–88. https://doi.org/10.1159/000444807
   PubMed Web of Science ®Google Scholar
• Kumarasamy, C., Sabarimurugan, S., Madurantakam, R. M., Lakhotiya, K., Samiappan, S., Baxi, S., Nachimuthu, R., Gothandam, K. M., & Jayaraj, R. (2019). Prognostic significance of blood inflammatory biomarkers NLR, PLR, and LMR in cancer — A protocol for systematic review and meta-analysis. Medicine, 98(24), e14834. https://doi.org/10.1097/MD.0000000000014834
   PubMed Web of Science ®Google Scholar
• Kumar, R., Geuna, E., Michalarea, V., Guardascione, M., Naumann, U., Lorente, D., Kaye, S., & De Bono, J. (2015). The neutrophil–lymphocyte ratio and its utilisation for the management of cancer patients in early clinical trials. British Journal of Cancer, 112(7), 1157–1165. https://doi.org/10.1038/bjc.2015.67
   PubMedGoogle Scholar
• Lee, S. H. (2019). Chemotherapy for lung cancer in the era of personalized medicine. Tuberculosis and Respiratory Diseases, 82(3), 179–189. https://doi.org/10.4046/trd.2018.0068
   PubMed Web of Science ®Google Scholar
• Lekander, M., Fürst, C. J., Rotstein, S., Blomgren, H., & Fredrikson, M. (1996). Social support and immune status during and after chemotherapy for breast cancer. Acta oncologica, 35(1), 31–37. https://doi.org/10.3109/02841869609098476
   PubMed Web of Science ®Google Scholar
• Li, W., Dan, G., Jiang, J., Zheng, Y., Zheng, X., & Deng, D. (2016). Repeated iodine-125 seed implantations combined with external beam radiotherapy for the treatment of locally recurrent or metastatic stage III/IV non-small cell lung cancer: A retrospective study. Radiation Oncology, 11(1), 1–8. https://doi.org/10.1186/s13014-016-0688-5
   PubMedGoogle Scholar
• Ly, S., Lehman, M., Liu, H., Hukins, C., Murphy, M., Dauth, M., Devine, M. S., & Mai, G. T. (2020). Incidence of hippocampal metastases in non‐small‐cell lung cancer. Journal of Medical Imaging and Radiation Oncology, 64(4), 586–590. https://doi.org/10.1111/1754-9485.13079
   PubMedGoogle Scholar
• Massaro, A. N., Chang, T., Baumgart, S., McCarter, R., Nelson, K. B., & Glass, P. (2014). Biomarkers S100b and NSE predict outcome in hypothermia-treated encephalopathic newborns. Pediatric Critical Care Medicine: A Journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies, 15(7), 615. https://doi.org/10.1097/PCC.0000000000000155
   PubMed Web of Science ®Google Scholar
• McLean, L. M., Walton, T., Rodin, G., Esplen, M. J., & Jones, J. M. (2013). A couple‐based intervention for patients and caregivers facing end‐stage cancer: Outcomes of a randomized controlled trial. Psycho‐oncology, 22(1), 28–38. https://doi.org/10.1002/pon.2046
   PubMed Web of Science ®Google Scholar
• Oeki, M., Mogami, T., & Hagino, H. (2012). Self-perceived burden in patients with cancer: Scale development and descriptive study. European Journal of Oncology Nursing, 16(2), 145–152. https://doi.org/10.1016/j.ejon.2011.04.010
   PubMed Web of Science ®Google Scholar
• Patel, S. P., & Kurzrock, R. (2015). PD-L1 expression as a predictive biomarker in cancer ImmunotherapyPD-L1 IHC as a predictive biomarker in cancer immunotherapy. Molecular Cancer Therapeutics, 14(4), 847–856. https://doi.org/10.1158/1535-7163.MCT-14-0983
   PubMed Web of Science ®Google Scholar
• Petersen, C. L. (2020). Spiritual care: Minimizing the vulnerability of parents whose children with cancer face the end of life. Journal of Pediatric Oncology Nursing, 37(2), 105–115. https://doi.org/10.1177/1043454219887509
   PubMedGoogle Scholar
• Rehse, B., & Pukrop, R. (2003). Effects of psychosocial interventions on quality of life in adult cancer patients: Meta analysis of 37 published controlled outcome studies. Patient Education and Counseling, 50(2), 179–186. https://doi.org/10.1016/S0738-3991(02)00149-0
   PubMed Web of Science ®Google Scholar
• Rosell, R., & Karachaliou, N. (2016). Large-scale screening for somatic mutations in lung cancer. The Lancet, 387(10026), 1354–1356. https://doi.org/10.1016/S0140-6736(15)01125-3
   PubMed Web of Science ®Google Scholar
• Simmons, L. A. (2007). Self-perceived burden in cancer patients: Validation of the Self-perceived Burden Scale. Cancer Nursing, 30(5), 405–411. https://doi.org/10.1097/01.NCC.0000290816.37442.af
   PubMedGoogle Scholar
• Sun, M., Zhao, W., Xie, Q., Zhan, Y., & Wu, B. (2015). Lentinan reduces tumor progression by enhancing gemcitabine chemotherapy in urothelial bladder cancer. Surgical Oncology, 24(1), 28–34. https://doi.org/10.1016/j.suronc.2014.11.002
   PubMedGoogle Scholar
• Vannitamby, A., Seow, H. J., Anderson, G., Vlahos, R., Thompson, M., Steinfort, D., Irving, L. B., & Bozinovski, S. (2017). Tumour-associated neutrophils and loss of epithelial PTEN can promote corticosteroid-insensitive MMP-9 expression in the chronically inflamed lung microenvironment. Thorax, 72(12), 1140–1143. https://doi.org/10.1136/thoraxjnl-2016-209389
   PubMedGoogle Scholar
• Wang, X. -F., Wu, Y. -H., Wang, M. -S., & Wang, Y. -S. (2014). CEA, AFP, CA125, CA153 and CA199 in malignant pleural effusions predict the cause. Asian Pacific Journal of Cancer Prevention, 15(1), 363–368. https://doi.org/10.7314/APJCP.2014.15.1.363
   PubMedGoogle Scholar
• Xiong, G., Lei, T., Dong, S., Xu, L., Li, M., & Wang, R. (2022). Roles of CD3, CD4 and CD8 in synovial lymphocytes of rheumatoid arthritis. Polish Journal of Pathology, 73(1), 21–26. https://doi.org/10.5114/pjp.2022.117173
   PubMedGoogle Scholar
• Youssef, M., Paish, E. C., Murray, J. C., Farag, N. M., Saleh, K., & Ellis, I. (2015). Tumor infiltrating T lymphocytes and apoptosis in colorectal cancer. The Egyptian Journal of Immunology, 22(1), 19–28.
   PubMedGoogle Scholar